MarketInOut Stock Screener Log In | Sign Up

Endonovo Therapeutics Inc

OTC • Healthcare • Biotechnology • Quote as of 11/10/2026
Endonovo Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0904 mln
Float1,361 mln
Earnings Date11/18/2024

Piotroski F-Score

3 / 9
Below average

Relative Strength

58 / 100
Slightly ahead

ROE

7.75
Low

ROA

-9,208
Deeply negative

Business Description

Endonovo Therapeutics is a California-based medical device company that develops technology designed to support the body's natural healing processes without surgery or drugs. Its flagship product, SofPulse, uses targeted electromagnetic energy to help patients manage pain, reduce swelling, and recover from soft tissue injuries and surgical procedures. The company is also exploring broader applications of this technology for serious conditions affecting the heart, kidneys, liver, and circulatory system.

Key Fundamentals

EPS-0.00
ROE7.75
RPS0.00
ROIC-4.01
ROA-9,208
Interest Cover-0.83
EBITDA, mln-1.02
EV / EBITDA-6.94
EV / EBIT-6.94
Revenue, mln0.26

Quote Details

Last 0.000001
Change -0.000099 (-99%)
Open 0.000001
Volume 100,000
Turnover 0.1
Average Volume 507,916

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 52 / 100   
1 Month -99% 0 / 100   
2 Months -98% 1 / 100   
6 Months -99.26% 1 / 100   
1 Year -99.6% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog